Catherine E. Rice
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Catherine E. Rice has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
Kim Van Naarden Braun
National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
3 shared publicationsAnita Washington
Research Triangle Institute International, Atlanta, GA 30341, USA
2 shared publicationsF. John Meaney
College of Public Health (SP) and Department of Pediatrics (CC and FJM), University of Arizona, Tucson 85724, USA
2 shared publicationsJon Baio
National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
2 shared publicationsJoyce Nicholas
College of Medicine, Medical University of South Carolina, Charleston South Caralina 29403, USA
2 shared publicationsMarshalyn Yeargin-Allsopp
National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, USA
2 shared publications
Latest Publications
- 14 March 2021
- Published by Springer Nature
- p. 4657-4659
Study Design Impact on Prevalence
- 14 March 2021
- Published by Springer Nature
- p. 2406-2409
Immigrant Status (Epidemiological Studies)
- 1 January 2013
- Published by Springer Nature
- p. 3020-3021
Study Design Impact on Prevalence
- 1 January 2013
- Published by Springer Nature
- p. 3120-3125
Time Trends in Diagnosis
- 1 January 2013
- Published by Springer Nature
- p. 1554-1557
Immigrant Status (Epidemiological Studies)
- 29 November 2012
- Published by Springer Nature in Public Health Reviews
- Vol. 34 (2) , 1-22
Evaluating Changes in the Prevalence of the Autism Spectrum Disorders (ASDs)
Autism spectrum disorders (ASDs) are estimated to occur among about one percent of children in the United States. This estimate is in line with estimates from other industrialized countries. However, the identified prevalence of ASDs has increased significantly in a short time period based on data from multiple studies including the U.S. Centers for Disease Control and Prevention’s (CDC) Autism and Developmental Disabilities Monitoring (ADDM) Network. Whether increases in ASD prevalence are partly attributable to a true increase in the risk of developing ASD or solely to changes in community awareness and identification patterns is not known. It is clear that more children are identified with an ASD now than in the past and the impact on individuals, families, and communities is significant. However, disentangling the many potential reasons for ASD prevalence increases has been challenging. Understanding the relative contribution of multiple factors such as variation in study methods, changes in diagnostic and community identification, and potential changes in risk factors is an important priority for the ADDM Network and for CDC. This article summarizes the discussion from a workshop that was co-sponsored by CDC and Autism Speaks as a forum for sharing knowledge and opinions of a diverse range of stakeholders about changes in ASD prevalence. Panelists discussed recommendations for building on existing infrastructure and developing new initiatives to better understand ASD trends. The information, research, and opinions shared during this workshop add to the knowledge base about ASD prevalence in an effort to stimulate further work to understand the multiple reasons behind increasing ASD prevalence.
- 29 November 2012
- Published by Springer Nature in Public Health Reviews
- Vol. 34 (2) , 1-22
Evaluating Changes in the Prevalence of the Autism Spectrum Disorders (ASDs)
Autism spectrum disorders (ASDs) are estimated to occur among about one percent of children in the United States. This estimate is in line with estimates from other industrialized countries. However, the identified prevalence of ASDs has increased significantly in a short time period based on data from multiple studies including the U.S. Centers for Disease Control and Prevention’s (CDC) Autism and Developmental Disabilities Monitoring (ADDM) Network. Whether increases in ASD prevalence are partly attributable to a true increase in the risk of developing ASD or solely to changes in community awareness and identification patterns is not known. It is clear that more children are identified with an ASD now than in the past and the impact on individuals, families, and communities is significant. However, disentangling the many potential reasons for ASD prevalence increases has been challenging. Understanding the relative contribution of multiple factors such as variation in study methods, changes in diagnostic and community identification, and potential changes in risk factors is an important priority for the ADDM Network and for CDC. This article summarizes the discussion from a workshop that was co-sponsored by CDC and Autism Speaks as a forum for sharing knowledge and opinions of a diverse range of stakeholders about changes in ASD prevalence. Panelists discussed recommendations for building on existing infrastructure and developing new initiatives to better understand ASD trends. The information, research, and opinions shared during this workshop add to the knowledge base about ASD prevalence in an effort to stimulate further work to understand the multiple reasons behind increasing ASD prevalence.
- 1 January 2011
- Published by American Psychological Association (APA)
Autism Spectrum Screening Questionnaire--Mandarin Chinese Version
- 1 January 2011
- Published by American Psychological Association (APA)
Autism Spectrum Screening Questionnaire--Mandarin Chinese Version
- 1 July 2010
- Published by Elsevier in Disability and Health Journal
- Vol. 3 (3) , 186-201
Changes in autism spectrum disorder prevalence in 4 areas of the United States
- 1 July 2010
- Published by Elsevier in Disability and Health Journal
- Vol. 3 (3) , 186-201
Changes in autism spectrum disorder prevalence in 4 areas of the United States
- 12 February 2007
- Published by Wiley in Paediatric and Perinatal Epidemiology
- Vol. 21 (2) , 179-190
A public health collaboration for the surveillance of autism spectrum disorders
Summary: Autism spectrum disorders (ASDs) represent a range of behavioural phenotypes defined by impaired development in social interaction, communication, imagination, and range of interests or behaviours. The aetiology and epidemiology of these serious developmental disabilities (DDs) are poorly understood. Estimates of the population prevalence of ASDs have varied widely within the US and abroad, with increasing estimates in most of the recent studies. In an effort to improve our understanding of the prevalence, population characteristics and public health impact of these conditions, the Centers for Disease Control and Prevention has funded a multi‐site surveillance network for ASDs and other DDs that consists of programmes known as the Autism and Developmental Disabilities Monitoring (ADDM) network which conducts surveillance activities and the Centers for Autism and Developmental Disabilities Research and Epidemiology (CADDRE) which also conducts surveillance in addition to special research studies related to the ASDs. This collaboration will be referred to hereafter as the ADDM Network. The ADDM Network is implementing a multiple‐source surveillance programme to determine population prevalence and characteristics of ASDs and other DDs. This paper describes the collaborative efforts and explains the methods in developing this coordinated public health surveillance network to provide an ongoing source of high‐quality data on ASDs.
- 12 February 2007
- Published by Wiley in Paediatric and Perinatal Epidemiology
- Vol. 21 (2) , 179-190
A public health collaboration for the surveillance of autism spectrum disorders
Summary: Autism spectrum disorders (ASDs) represent a range of behavioural phenotypes defined by impaired development in social interaction, communication, imagination, and range of interests or behaviours. The aetiology and epidemiology of these serious developmental disabilities (DDs) are poorly understood. Estimates of the population prevalence of ASDs have varied widely within the US and abroad, with increasing estimates in most of the recent studies. In an effort to improve our understanding of the prevalence, population characteristics and public health impact of these conditions, the Centers for Disease Control and Prevention has funded a multi‐site surveillance network for ASDs and other DDs that consists of programmes known as the Autism and Developmental Disabilities Monitoring (ADDM) network which conducts surveillance activities and the Centers for Autism and Developmental Disabilities Research and Epidemiology (CADDRE) which also conducts surveillance in addition to special research studies related to the ASDs. This collaboration will be referred to hereafter as the ADDM Network. The ADDM Network is implementing a multiple‐source surveillance programme to determine population prevalence and characteristics of ASDs and other DDs. This paper describes the collaborative efforts and explains the methods in developing this coordinated public health surveillance network to provide an ongoing source of high‐quality data on ASDs.